Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.820
-0.015 (-0.39%)
At close: Jul 13, 2026, 4:00 PM EDT
3.650
-0.170 (-4.45%)
After-hours: Jul 13, 2026, 7:59 PM EDT
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $16.2 million as of July 13, 2026. Its market cap has increased by 79.78% in one year.
Market Cap
16.20M
Enterprise Value
13.38M
1-Year Change
79.78%
Ranking
Category
Stock Price
$3.82
Market Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $193.31M to $16.20M, a decrease of -91.62%. That is a compound annual growth rate of -28.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 16.20M | 235.17% |
| Dec 31, 2025 | 4.83M | -40.68% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 17.81M |
| Quince Therapeutics | 17.15M |
| BioVie | 17.12M |
| Pasithea Therapeutics | 16.45M |
| Jasper Therapeutics | 16.22M |
| Lexaria Bioscience | 16.03M |
| Citius Pharmaceuticals | 16.00M |
| Vyome Holdings | 15.79M |